Your browser doesn't support javascript.
loading
Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.
Kolobova, Irina; Nyaku, Mawuli Kwame; Karakusevic, Anna; Bridge, Daisy; Fotheringham, Iain; O'Brien, Megan.
Affiliation
  • Kolobova I; Center for Observational and Real World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
  • Nyaku MK; Center for Observational and Real World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
  • Karakusevic A; Adelphi Values PROVE, Cheshire, UK.
  • Bridge D; Adelphi Values PROVE, Cheshire, UK.
  • Fotheringham I; Adelphi Values PROVE, Cheshire, UK.
  • O'Brien M; Center for Observational and Real World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
Hum Vaccin Immunother ; 18(5): 2055422, 2022 11 30.
Article in En | MEDLINE | ID: mdl-35536017
To reduce morbidity and mortality associated with vaccine-preventable diseases (VPD), it is imperative that vaccination programs are implemented and prioritized throughout all stages of life across all populations. This study aimed to determine vaccine uptake and barriers to vaccination against VPDs among at-risk adult populations in the United States. We conducted a systematic literature review for articles published between January 2010 and June 2020 and identified 153 publications. The review identified 17 at-risk populations. Vaccine uptake was suboptimal among many populations, with factors including age, gender, and disease severity, associated with uptake. This review identified several barriers that impact vaccine uptake among at-risk populations, with concerns over safety, vaccine costs, lack of insurance, and lack of provider recommendation commonly reported across populations. Embracing a national life-course immunization framework that integrates developing policies, guidelines, and education would be a step to addressing these barriers.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Vaccine-Preventable Diseases Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Hum Vaccin Immunother Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Vaccine-Preventable Diseases Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Hum Vaccin Immunother Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States